(Q24186558)

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Optimising inhaled mannitol for cystic fibrosis in an adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Inhaled mannitol improves lung function in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Update in cystic fibrosis 2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Evidence of mast cell activation and leukotriene release after mannitol inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Other mucoactive agents for cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Effects of terbutaline in combination with mannitol on mucociliary clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Pathogenesis of lung disease in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Cystic fibrosis mortality and survival in the UK: 1947-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Dornase alfa for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Cystic fibrosis: basic science

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

High treatment burden in adults with cystic fibrosis: challenges to disease self-management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Nebulised hypertonic saline for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Inhaled hyperosmolar agents for bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Inhalation of dry-powder mannitol increases mucociliary clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

Effects of chemical mediators of anaphylaxis on ciliary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

7 January 2021

Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

7 January 2021

Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

7 January 2021

A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

7 January 2021

Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008649.PUB2

7 January 2021

10.1002/14651858.CD008649.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

26451533

1 reference

Consolidated OpenCitations Corpus – April 2017